ÅǸ޴º
¹øÈ£ | ±¸ºÐ | Á¦¸ñ |
---|---|---|
173 | (±¹³»)KCI | Àç¹ßÇÑ ÀڱðæºÎ¾Ï¿¡¼ ÀüÀ̼º °©»ó¼±¾Ï |
172 | (±¹¿Ü)SCIE | Antitumor Activity and Acquired Resistance Mechanism of Dovitinib (TKI258) in RET-Rearranged Lung Adenocarcinoma |
171 | (±¹¿Ü)SCI | Antitumor Activity and Acquired Resistance Mechanism of Dovitinib (TKI258) in RETRearranged Lung Adenocarcinoma |
170 | (±¹¿Ü)SCI | Efficacy and Safety of Edoxaban for Treatment of Venous Thromboembolism: A Subanalysis of East Asian Patients in the Hokusai-VTE Trial. |
169 | (±¹¿Ü)SCI | Congenital thrombotic thrombocytopenic purpura (Upshaw-Schulman syndrome) caused by novel ADAMTS13 mutations. |
168 | (±¹¿Ü)SCIE | 3¡¯-UTR polymorphisms in the miRNA machinery genes DROSHA, DICER1, RAN, and XPO5 are associated with colorectal cancer risk in a Korean population |
167 | (±¹¿Ü)SCIE | Genetic variants in 3¡¯-UTRs of methylenetetrahydrofolate reductase (MTHFR) predict colorectal cancer susceptibility in Korean |
166 | (±¹¿Ü)SCI | An open label, multicenter, phase II study of dovitinib in advanced thyroid cancer |
165 | (±¹¿Ü)SCI | Long-term Clinical Outcomes of Splanchnic Vein Thrombosis: Results of an International Registry. |
164 | (±¹³»)SCIE | Predisposing roles of paraoxonase-1 genetic variants in Korean ischemic stroke patients |
Copyright ¨Ï chamc, All rights reserved.